Hypoparathyroidism
A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.
Subtype terms (1)
More specific conditions that are subtypes of Hypoparathyroidism in the MeSH hierarchy.
- 22q11 Deletion Syndrome
7 drugs (6 approved, 1 experimental)
Drugs by status
Approved for this indication (5)
Phase 4 trials (9)
Phase 3 trials (3)
Phase 1 trials (2)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (10)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (3)